ZOLL’s Temperature Management Solution Successfully Revives 17 Pilgrims from Heat Stroke During the Hajj Pilgrimage in Mecca

  ZOLL’s Temperature Management Solution Successfully Revives 17 Pilgrims from
  Heat Stroke During the Hajj Pilgrimage in Mecca

Business Wire

CHELMSFORD, Mass. -- December 13, 2012

ZOLL^® Medical Corporation, a manufacturer of medical devices and related
software solutions, announced today that 17 pilgrims suffering heat stroke
during the annual Hajj pilgrimage to Mecca were successfully treated using
ZOLL’s intravascular temperature management (IVTM™) solution. The patients,
both male and female, ranged in age from 44 to the oldest at 76.

Heat stroke can be fatal if not properly and promptly treated. The severe
desert heat, associated sun-related hazards, and crowding present during the
Hajj trigger emergency situations such as heat stroke. Daytime temperatures
this year hovered around 95ºF (35ºC) at the world’s largest annual gathering
in October, which attracted over 3 million Muslims from around the world.

To prepare for these conditions, the Saudi Arabia Ministry of Health purchased
five additional IVTM systems after determining last year that ZOLL’s
intravascular approach was the “best in class” technology for treating severe
heat stroke cases. When cooler temperatures prevailed in 2011, 10 cases of
heat stroke were reported, two of which were treated with ZOLL’s IVTM with
excellent results. The other, not as serious cases were treated with standard

According to Abdulrahman Alduailij, CEO of Hospital Automation Technology,
ZOLL’s distributor for temperature management equipment in Saudi Arabia, a
clinical trial showing that ZOLL’s temperature management system can reduce
the fever burden by 64% over surface cooling^1 was influential in the Ministry
of Health’s initial purchasing decision.

“After witnessing the superior clinical efficiency ZOLL’s intravascular
approach provides in reaching and maintaining target temperature when compared
to other methods, such as surface cooling, the Saudi government decided to
expand use of the technology this year,” said Alduailij. “This technology
gives our clinicians the power and control they need to rapidly, safely and
effectively manage core body temperature, and reduces their workload since it
doesn’t require constant monitoring.”

“The process of cooling the body can limit potential damage to the brain, and
other organs, resulting in lives saved that might otherwise be lost,” said
Richard A. Packer, Chief Executive Officer of ZOLL. “Use of the technology in
this instance validates the power and positive impact of ZOLL’s intravascular

About Heat Stroke

A heat stroke is a life-threatening condition resulting from long and extreme
exposure to heat, in which a person can't sweat enough to lower body
temperature. When the weather is hot, the body works overtime trying to stay
cool. Excess heat escapes through sweating, exhalation of warmed air, and
increased blood flow to the skin. Hot weather can overwhelm these mechanisms,
which can lead to the failure of body's heat regulating system, causing
rapidly increased body temperature and dehydration.


ZOLL IVTM provides cooling and warming from a catheter inserted into a
patient’s vein. This provides better control of the core body temperature by
directly cooling or warming the patient’s blood as it flows through the body.
This catheter is connected to the Thermogard XP^® console which, when used to
induce hypothermia, circulates ice-cold saline solution inside a balloon
catheter. After a period of therapeutic hypothermia, typically 12-24 hours,
the system slowly and accurately rewarms the patient back to normal body
temperature. Since the saline flows only within the catheter, no fluid is
infused into the patient. The ZOLL IVTM system is efficient, precise and easy
to use, and frees up clinical staff to attend to other patient needs.

ZOLL IVTM offers a variety of catheters with placement options to handle
specific patient challenges. Options for catheter placement include femoral,
subclavian, and internal jugular.

About ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets
medical devices and software solutions that help advance emergency care and
save lives, while increasing clinical and operational efficiencies. With
products for defibrillation and monitoring, circulation and CPR feedback, data
management, fluid resuscitation, and therapeutic temperature management, ZOLL
provides a comprehensive set of technologies that help clinicians, EMS and
fire professionals, and lay rescuers treat victims needing resuscitation and
critical care. For more information, visit www.zoll.com.

About Asahi Kasei

The Asahi Kasei Group is a diversified group of companies led by holding
company Asahi Kasei Corp., with operations in the chemicals and fibers, homes
and construction materials, electronics, and health care business sectors. Its
health care operations include devices and systems for critical care,
dialysis, therapeutic apheresis, transfusion, and manufacture of
biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and
nutritional products. With more than 25,000 employees around the world, the
Asahi Kasei Group serves customers in more than 100 countries. For more
information, visit www.asahi-kasei.co.jp/asahi/en/.

Copyright © 2012 ZOLL Medical Corporation. All rights reserved. IVTM,
Thermogard XP, and ZOLL are trademarks and/or registered trademarks of ZOLL
Medical Corporation in the United States and/or other countries. Asahi Kasei
is a registered trademark of Asahi Kasei Corporation. All trademarks are the
property of their respective owners.

^1 Critical Care Medicine Vol. 32, No. 2, Deringer, Michael N., Treatment of
fever in the neurologic intensive care unit of a catheter-based heat exchange
system. 2004; 559-564


ZOLL Medical Corporation
Diane Egan, +1-978-421-9637
Press spacebar to pause and continue. Press esc to stop.